region stringclasses 1
value | symbol stringlengths 1 5 | exchange stringclasses 8
values | quote_type stringclasses 2
values | currency stringclasses 1
value | name stringlengths 2 84 ⌀ | sector stringclasses 12
values | industry stringclasses 148
values | close float64 0 5.92k ⌀ | volume float64 0 134M ⌀ | market_cap float64 22.4k 2,794B ⌀ | updated_at timestamp[ns] | long_business_summary stringlengths 50 5.19k ⌀ | status stringclasses 1
value | __index_level_0__ int64 0 7.31k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
US | IGA | NYQ | EQUITY | USD | Voya Global Advantage and Premium Opportunity Fund | Financial Services | Asset Management | 8.07 | 60,395 | 127,794,752 | 2023-10-17T13:24:11.996349 | Voya Global Advantage and Premium Opportunity Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by Voya Investments, LLC, Voya Investment Management Co. LLC, and NNIP Advisors B.V. It invests in public equity markets across the globe. The fund seeks to invest i... | null | 3,301 |
US | IGBH | PCX | ETF | USD | iShares Interest Rate Hedged Long-Term Corporate Bond ETF | null | null | 23.79 | 6,419 | 62,186,932 | 2023-10-17T13:24:19.523705 | The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in component securities and instruments in the fund’s underlying index and/or bonds included in the underlying index of the underlying f... | null | 3,302 |
US | IGC | ASE | EQUITY | USD | IGC Pharma, Inc. | Healthcare | Biotechnology | 0.3328 | 73,714 | 20,131,382 | 2023-10-17T13:24:24.992390 | IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease compris... | null | 3,303 |
US | IGD | NYQ | EQUITY | USD | Voya Global Equity Dividend and Premium Opportunity Fund | Financial Services | Asset Management | 4.8 | 222,960 | 387,542,272 | 2023-10-17T13:24:32.709380 | Voya Global Equity Dividend and Premium Opportunity Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by Voya Investments, LLC and NNIP Advisors B.V. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating... | null | 3,304 |
US | IGE | BTS | ETF | USD | iShares North American Natural Resources ETF | null | null | 41.58 | 170,544 | 600,984,768 | 2023-10-17T13:24:40.099296 | The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap... | null | 3,305 |
US | IGHG | BTS | ETF | USD | ProShares Investment Grade—Interest Rate Hedged | null | null | 73.802 | 8,556 | 285,874,848 | 2023-10-17T13:24:46.852294 | The index is comprised of (a) long positions in USD-denominated investment grade corporate bonds issued by both U.S. and foreign domiciled companies; and (b) short positions in U.S. Treasury notes or bonds ("Treasury Securities") of, in aggregate, approximate equivalent duration to the investment grade bonds. The fund ... | null | 3,306 |
US | IGI | NYQ | EQUITY | USD | Western Asset Investment Grade Defined Opportunity Trust Inc. | Financial Services | Asset Management | 15.48 | 7,425 | 168,903,360 | 2023-10-17T13:24:53.584483 | Western Asset Investment Grade Defined Opportunity Trust Inc. is a close-ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by Western Asset Management Company, Western Asset Management Company Pte. Ltd, Western Asset Management Company Ltd., and Western Asset... | null | 3,307 |
US | IGIC | NCM | EQUITY | USD | International General Insurance Holdings Ltd. | Financial Services | Insurance - Diversified | 10.93 | 79,957 | 507,406,144 | 2023-10-17T13:24:59.650446 | International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. It operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance. The company underwrites a portfolio of specialty risks, including energy, property, construction and engineering... | null | 3,308 |
US | IGLB | PCX | ETF | USD | iShares 10+ Year Investment Grade Corporate Bond ETF | null | null | 46.66 | 522,762 | 1,855,269,248 | 2023-10-17T13:25:06.758979 | The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index ... | null | 3,309 |
US | IGM | PCX | ETF | USD | iShares Expanded Tech Sector ETF | null | null | 390.83 | 31,649 | 3,117,308,928 | 2023-10-17T13:25:12.354254 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. A significant portion of the underlying index is represented by securi... | null | 3,310 |
US | IGMS | NMS | EQUITY | USD | IGM Biosciences, Inc. | Healthcare | Biotechnology | 4.41 | 366,546 | 259,143,712 | 2023-10-17T13:25:17.939235 | IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's product candidate, including imvotamab (IGM-2323), an IgM-based CD20 x CD3 bispecific antibody T cell engage... | null | 3,311 |
US | IGN | PCX | ETF | USD | iShares North American Tech-Multimedia Networking ETF | null | null | 57.8868 | 2,431 | 52,536,912 | 2023-10-17T13:25:26.073648 | The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S.-traded stocks of com... | null | 3,312 |
US | IGPT | PCX | ETF | USD | Invesco Dynamic Software ETF | null | null | 33.1189 | 9,654 | 163,684,160 | 2023-10-17T13:25:33.780831 | The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of securities of companies with significant exposure to technologies or products that contribute to future software development through direct revenue. The fund is non-d... | null | 3,313 |
US | IGR | NYQ | EQUITY | USD | CBRE Global Real Estate Income Fund | Financial Services | Asset Management | 4.36 | 533,159 | 620,062,592 | 2023-10-17T13:25:39.207808 | CBRE Clarion Global Real Estate Income Fund specializes in investments in various property types, including office, retail, diversified, apartments, industrials, hotels, healthcare, and storage. It invests in the public equity markets across the developed markets of North America, Europe, Australia, and Asia. The fund ... | null | 3,314 |
US | IGRO | BTS | ETF | USD | iShares International Dividend Growth ETF | null | null | 59.2 | 32,862 | 617,647,680 | 2023-10-17T13:25:46.261788 | The fund seeks to track the investment results of the index, which is a dividend dollars weighted index that seeks to measure the performance of international equities selected based on a consistent history of growing dividends. It will invest at least 80% of its assets in the component securities of the index and in i... | null | 3,315 |
US | IGT | NYQ | EQUITY | USD | International Game Technology PLC | Consumer Cyclical | Gambling | 30.58 | 707,599 | 6,183,044,608 | 2023-10-17T13:25:54.188955 | International Game Technology PLC operates and provides gaming technology products and services in North America, Europe, the Middle East, Africa, Asia-Pacific, Latin America, and the Caribbean. It operates in three segments: Global Lottery, Global Gaming, and Digital & Betting. The company designs, sells, operates, an... | null | 3,316 |
US | IGTA | NGM | EQUITY | USD | Inception Growth Acquisition Limited | Financial Services | Shell Companies | 10.64 | 471 | 75,671,680 | 2023-10-17T13:26:01.352733 | Inception Growth Acquisition Limited does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on sourcing opportunities in the technolog... | null | 3,317 |
US | IGV | BTS | ETF | USD | iShares Expanded Tech-Software Sector ETF | null | null | 349.28 | 753,278 | 6,276,216,320 | 2023-10-17T13:26:08.879051 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index measures the performance of U.S.-traded stocks from the soft... | null | 3,318 |
US | IH | NYQ | EQUITY | USD | iHuman Inc. | Consumer Defensive | Education & Training Services | 2.01 | 37,308 | 109,173,864 | 2024-05-22T17:29:38.036874 | iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman ... | null | 3,319 |
US | IHD | NYQ | EQUITY | USD | Voya Emerging Markets High Dividend Equity Fund | Financial Services | Asset Management | 4.83 | 55,847 | 87,973,456 | 2023-10-17T13:26:21.885121 | Voya Emerging Markets High Dividend Equity Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by ING Investment Management Advisors B.V. and Voya Investments, LLC. It invests in public equity markets of emerging market countries across the globe. The fund seeks ... | null | 3,320 |
US | IHDG | PCX | ETF | USD | WisdomTree International Hedged Quality Dividend Growth Fund | null | null | 38.62 | 361,173 | 1,704,387,328 | 2023-10-17T13:26:29.078696 | The fund will invest at least 80% of its total assets in component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. The index consists of dividend-paying common stocks with growth characteristics of ... | null | 3,321 |
US | IHE | PCX | ETF | USD | iShares U.S. Pharmaceuticals ETF | null | null | 179.5619 | 5,035 | 353,912,800 | 2023-10-17T13:26:34.925714 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals s... | null | 3,322 |
US | IHF | PCX | ETF | USD | iShares U.S. Healthcare Providers ETF | null | null | 252.05 | 23,314 | 873,724,224 | 2023-10-17T13:26:40.741165 | The index measures the performance of the healthcare providers sector of the U.S. equity market, as defined by SPDJI. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component... | null | 3,323 |
US | IHG | NYQ | EQUITY | USD | InterContinental Hotels Group PLC | Consumer Cyclical | Lodging | 72.91 | 104,242 | 12,178,134,016 | 2023-10-17T13:26:47.552190 | InterContinental Hotels Group PLC owns, manages, franchises, and leases hotels in the Americas, Europe, Asia, the Middle East, Africa, and Greater China. The company operates hotels under the Six Senses, Regent, InterContinental Hotels & Resorts, Vignette Collection, Kimpton Hotels & Restaurants, Hotel Indigo, voco, HU... | null | 3,324 |
US | IHI | PCX | ETF | USD | iShares U.S. Medical Devices ETF | null | null | 45.37 | 1,691,996 | 5,074,343,424 | 2023-10-17T13:26:54.626899 | The fund will invest at least 80% of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities... | null | 3,325 |
US | IHIT | NYQ | EQUITY | USD | Invesco High Income 2023 Target Term Fund | Financial Services | Asset Management | 6.84 | 70,081 | 164,672,992 | 2023-10-17T13:27:02.385305 | Invesco High Income 2023 Target Term Fund is a closed ended fixed income mutual fund launched and managed by Invesco Advisers, Inc. The fund invests in fixed income markets of the United States. It also invests in real estate debt securities including commercial mortgage-backed securities. The fund employs fundamental ... | null | 3,326 |
US | IHRT | NMS | EQUITY | USD | iHeartMedia, Inc. | Communication Services | Broadcasting | 2.63 | 420,296 | 345,899,200 | 2023-10-17T13:27:09.541787 | iHeartMedia, Inc. operates as a media and entertainment company worldwide. The company operates through three segments: Multiplatform Group, Digital Audio Group, and Audio & Media Services Group. The Multiplatform Group segment offers broadcast radio stations, sponsorship, and live and virtual events; and operates Prem... | null | 3,327 |
US | IHS | NYQ | EQUITY | USD | IHS Holding Limited | Communication Services | Telecom Services | 5.02 | 696,104 | 1,633,949,440 | 2023-10-17T13:27:17.659384 | IHS Holding Limited, together with its subsidiaries, owns, operates, and develops shared communications infrastructure in Nigeria, Sub-Saharan Africa, Latin America, and the Middle East and North Africa. It offers colocation and lease agreement, build-to-suit, inbuilding, small cell, fiber connectivity, and rural telep... | null | 3,328 |
US | IHT | ASE | EQUITY | USD | InnSuites Hospitality Trust | Real Estate | REIT - Hotel & Motel | 1.2 | 1,752 | 10,807,452 | 2023-10-17T13:27:25.359234 | InnSuites Hospitality Trust (NYSE American symbol: IHT) first listed on the NYSE in 1971 is headquartered in Phoenix, Arizona is an unincorporated Ohio Business. Trust that owns and manages hotels under the InnSuites Hotels name. IHT qualifies as a Real Estate Investment Trust (REIT) for tax treatment currently taxed a... | null | 3,329 |
US | IHTA | NYQ | EQUITY | USD | Invesco High Income 2024 Target Term Fund | null | null | 6.75 | 16,863 | 59,220,268 | 2023-10-17T13:27:31.641667 | null | null | 3,330 |
US | IHY | PCX | ETF | USD | VanEck International High Yield Bond ETF | null | null | 19.315 | 9,932 | 37,297,392 | 2023-10-17T13:27:39.149040 | The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index is comprised of below investment grade bonds issued by corporations located throughout the world (which may include emerging market countries) excluding the United States denominated in Euros, U.... | null | 3,331 |
US | IIF | NYQ | EQUITY | USD | Morgan Stanley India Investment Fund, Inc. | Financial Services | Asset Management | 22.29 | 31,928 | 226,447,552 | 2023-10-17T13:27:44.754473 | Morgan Stanley India Investment Fund, Inc. is a closed ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. The fund is co-managed by Morgan Stanley Investment Management Company. It invests in the public equity markets of India. The fund invests in stocks of companies operating ac... | null | 3,332 |
US | III | NGM | EQUITY | USD | Information Services Group, Inc. | Technology | Information Technology Services | 4.21 | 46,221 | 210,254,832 | 2023-10-17T13:27:52.267650 | Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; net... | null | 3,333 |
US | IIIN | NYQ | EQUITY | USD | Insteel Industries, Inc. | Industrials | Metal Fabrication | 32.23 | 39,184 | 636,806,336 | 2023-10-17T13:27:57.870452 | Insteel Industries, Inc., together with its subsidiaries, manufactures and markets steel wire reinforcing products for concrete construction applications. The company offers prestressed concrete strand (PC strand) and welded wire reinforcement (WWR) products. Its PC strand is a seven-wire strand that is used to impart ... | null | 3,334 |
US | IIIV | NMS | EQUITY | USD | i3 Verticals, Inc. | Technology | Software - Infrastructure | 19.65 | 128,896 | 688,139,648 | 2023-10-17T13:28:05.442821 | i3 Verticals, Inc. provides integrated payment and software solutions to small- and medium-sized businesses and organizations in education, non-profit, public sector, and healthcare markets in the United States. It operates in two segments, Merchant Services, and Proprietary Software and Payments. The company offers pa... | null | 3,335 |
US | IIM | NYQ | EQUITY | USD | Invesco Value Municipal Income Trust | Financial Services | Asset Management | 10.5 | 101,295 | 490,923,424 | 2023-10-17T13:28:13.544445 | Invesco Value Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited... | null | 3,336 |
US | IINN | NCM | EQUITY | USD | Inspira Technologies Oxy B.H.N. Ltd. | Healthcare | Medical Devices | 1.32 | 14,019 | 16,224,830 | 2023-10-17T13:28:19.866167 | Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented resp... | null | 3,337 |
US | IIPR | NYQ | EQUITY | USD | Innovative Industrial Properties, Inc. | Real Estate | REIT - Industrial | 75.48 | 201,494 | 2,177,025,536 | 2023-10-17T13:28:26.403425 | Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real e... | null | 3,338 |
US | IJH | PCX | ETF | USD | iShares Core S&P Mid-Cap ETF | null | null | 243.58 | 1,385,961 | 70,754,721,792 | 2023-10-17T13:28:34.746534 | The index measures the performance of the mid-capitalization sector of the U.S. equity market, as determined by SPDJI. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the componen... | null | 3,339 |
US | IJJ | PCX | ETF | USD | iShares S&P Mid-Cap 400 Value ETF | null | null | 97.84 | 138,255 | 6,612,985,856 | 2023-10-17T13:28:42.349798 | The index measures the performance of the mid-capitalization value sector of the U.S. equity market. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of it... | null | 3,340 |
US | IJK | PCX | ETF | USD | iShares S&P Mid-Cap 400 Growth ETF | null | null | 71.06 | 232,210 | 7,384,672,256 | 2023-10-17T13:28:50.588321 | The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash a... | null | 3,341 |
US | IJR | PCX | ETF | USD | iShares Core S&P Small-Cap ETF | null | null | 91.22 | 3,747,148 | 66,490,216,448 | 2023-10-17T13:28:57.957524 | The index measures the performance of the small-capitalization sector of the U.S. equity market, as determined by SPDJI. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the compon... | null | 3,342 |
US | IJS | PCX | ETF | USD | iShares S&P Small-Cap 600 Value ETF | null | null | 85.57 | 331,437 | 6,306,158,592 | 2023-10-17T13:29:05.592641 | The index measures the performance of the small-capitalization value sector of the U.S. equity market. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of ... | null | 3,343 |
US | IKNA | NGM | EQUITY | USD | Ikena Oncology, Inc. | Healthcare | Biotechnology | 4.21 | 61,072 | 186,736,736 | 2023-10-17T13:29:12.225056 | Ikena Oncology, Inc. operates as an oncology company that develops precision medicines to biomarker-defined patients with specific unmet needs in the United States. Its lead oncology product candidate is IK-930, a paralog selective inhibitor of the transcriptional enhanced associate domain, a transcription factor in th... | null | 3,344 |
US | IKT | NCM | EQUITY | USD | Inhibikase Therapeutics, Inc. | Healthcare | Biotechnology | 0.95 | 211,421 | 5,331,750 | 2023-10-17T13:29:20.285829 | Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gast... | null | 3,345 |
US | ILAG | NCM | EQUITY | USD | Intelligent Living Application Group Inc. | Industrials | Building Products & Equipment | 0.85 | 6,001 | 16,073,400 | 2023-10-17T13:29:28.363241 | Intelligent Living Application Group Inc., through its subsidiaries, manufactures and sells mechanical locksets to customers in the United States and Canada. Its mechanical locksets consist of deadbolts, entry locksets, privacy locksets, and passage locksets as well as storerooms locks. The company offers locksets for ... | null | 3,346 |
US | ILCB | PCX | ETF | USD | iShares Morningstar U.S. Equity ETF | null | null | 59.47 | 12,260 | 745,767,296 | 2023-10-17T13:29:36.377908 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S. stocks issued by... | null | 3,347 |
US | ILCG | PCX | ETF | USD | iShares Morningstar Growth ETF | null | null | 60.83 | 28,524 | 1,663,438,464 | 2023-10-17T13:29:42.336544 | The fund will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S. stocks issued by large-mid... | null | 3,348 |
US | ILCV | PCX | ETF | USD | iShares Morningstar Value ETF | null | null | 64.47 | 32,956 | 818,906,112 | 2023-10-17T13:29:48.404633 | The fund will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S. stocks issued by large-mid... | null | 3,349 |
US | ILF | PCX | ETF | USD | iShares Latin America 40 ETF | null | null | 24.95 | 678,641 | 1,411,757,312 | 2023-10-17T13:29:55.085775 | The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. It seeks to track the investment results of the S&P Latin America 40TM (th... | null | 3,350 |
US | ILLM | NCM | EQUITY | USD | illumin Holdings Inc. | Communication Services | Advertising Agencies | 1.67 | 70,531 | 84,095,608 | 2023-10-17T13:30:00.714593 | illumin Holdings Inc., a technology company, provides digital media solutions in the United States, Canada, Europe, Latin America, and internationally. The company offers a programmatic marketing platform that enables advertisers to connect with their audiences across online display, video, social, and mobile campaigns... | null | 3,351 |
US | ILMN | NMS | EQUITY | USD | Illumina, Inc. | Healthcare | Diagnostics & Research | 129.11 | 1,088 | 20,797,454,336 | 2023-10-17T13:30:06.130775 | Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, an... | null | 3,352 |
US | ILPT | NMS | EQUITY | USD | Industrial Logistics Properties Trust | Real Estate | REIT - Industrial | 2.57 | 4,316 | 167,527,088 | 2023-10-17T13:30:12.851131 | ILPT is a real estate investment trust focused on owning and leasing high quality distribution and logistics properties that serve the growing needs of e-commerce. As of June 30, 2023, ILPT's portfolio consisted of 413 properties containing approximately 60.0 million rentable square feet located in 39 states. Approxima... | null | 3,353 |
US | ILTB | PCX | ETF | USD | iShares Core 10+ Year USD Bond ETF | null | null | 46.6619 | 982 | 502,415,136 | 2023-10-17T13:30:19.583666 | The underlying index measures the performance of U.S. dollar-denominated taxable bonds that are rated either investment-grade or high yield with remaining maturities greater than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic ch... | null | 3,354 |
US | IMAB | NGM | EQUITY | USD | I-Mab | Healthcare | Biotechnology | 1.3 | 6,240 | 107,410,280 | 2023-10-17T13:30:26.567133 | I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting growth hormone, which has comp... | null | 3,355 |
US | IMAQ | NCM | EQUITY | USD | International Media Acquisition Corp. | Financial Services | Shell Companies | 11.24 | 20 | 96,020,632 | 2023-10-17T13:30:32.374943 | International Media Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the media and entertainment sector. International Media Acquisition Corp. ... | null | 3,356 |
US | IMAX | NYQ | EQUITY | USD | IMAX Corporation | Communication Services | Entertainment | 17.77 | 4,003 | 960,221,376 | 2023-10-17T13:30:39.799024 | IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates through three segments: IMAX Technology Network; IMAX Technology Sales and Maintenance; and Film Distribution and Post-Production. The company offers IMAX DMR, a proprietary t... | null | 3,357 |
US | IMCB | PCX | ETF | USD | iShares Morningstar Mid-Cap ETF | null | null | 59.2612 | 16,300 | 719,807,680 | 2023-10-17T13:30:45.600426 | The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S. stocks issued by... | null | 3,358 |
US | IMCC | NCM | EQUITY | USD | IM Cannabis Corp. | Healthcare | Drug Manufacturers - Specialty & Generic | 0.6291 | 45,182 | 8,343,425 | 2023-10-17T13:30:53.233231 | IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company s... | null | 3,359 |
US | IMCG | PCX | ETF | USD | iShares Morningstar Mid-Cap Growth ETF | null | null | 57.65 | 5,624 | 1,516,747,648 | 2023-10-17T13:30:59.262906 | The fund will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of U.S. stocks issued by mid-capit... | null | 3,360 |
US | IMCR | NMS | EQUITY | USD | Immunocore Holdings plc | Healthcare | Biotechnology | 50.54 | 1,674 | 2,472,025,088 | 2023-10-17T13:31:04.570777 | Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also developing other programs f... | null | 3,361 |
US | IMGN | NMS | EQUITY | USD | ImmunoGen, Inc. | Healthcare | Biotechnology | 14.64 | 17,165 | 3,681,867,008 | 2023-10-17T13:31:11.338327 | ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian ... | null | 3,362 |
US | IMKTA | NMS | EQUITY | USD | Ingles Markets, Incorporated | Consumer Defensive | Grocery Stores | 77.05 | 142 | 1,494,289,408 | 2023-10-17T13:31:18.472172 | Ingles Markets, Incorporated operates a chain of supermarkets in the southeast United States. It offers food products, including grocery, meat and dairy products, produce, frozen foods, and other perishables; and non-food products, which include fuel centers, pharmacies, health and beauty care products, and general mer... | null | 3,363 |
US | IMMP | NGM | EQUITY | USD | Immutep Limited | Healthcare | Biotechnology | 1.82 | 1,029 | 164,338,320 | 2023-10-17T13:31:24.677954 | Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb ... | null | 3,364 |
US | IMMR | NMS | EQUITY | USD | Immersion Corporation | Technology | Software - Application | 6.74 | 2,009 | 216,018,048 | 2023-10-17T13:31:32.753560 | Immersion Corporation, together with its subsidiaries, creates, designs, develop, and licenses haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It a... | null | 3,365 |
US | IMMX | NCM | EQUITY | USD | Immix Biopharma, Inc. | Healthcare | Biotechnology | 2.97 | 3,846 | 61,200,868 | 2023-10-17T13:31:38.696280 | Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-1... | null | 3,366 |
US | IMNM | NCM | EQUITY | USD | Immunome, Inc. | Healthcare | Biotechnology | 8.92 | 233 | 381,991,296 | 2023-10-17T13:31:46.749035 | Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an ant... | null | 3,367 |
US | IMNN | NCM | EQUITY | USD | Imunon, Inc. | Healthcare | Biotechnology | 0.98 | 1,534 | 9,180,503 | 2023-10-17T13:31:52.169170 | Imunon, Inc., a clinical stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The Company's lead clinical programs comprise IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical developme... | null | 3,368 |
US | IMO | ASE | EQUITY | USD | Imperial Oil Limited | Energy | Oil & Gas Integrated | 61.03 | 4,149 | 35,580,760,064 | 2023-10-17T13:31:58.086787 | Imperial Oil Limited engages in exploration, production, and sale of crude oil and natural gas in Canada. The company operates through three segments: Upstream, Downstream and Chemical segments. The Upstream segment explores for, and produces crude oil, natural gas, synthetic crude oil, and bitumen. The Downstream segm... | null | 3,369 |
US | IMOS | NMS | EQUITY | USD | ChipMOS TECHNOLOGIES INC. | Technology | Semiconductors | 23.86 | 450 | 871,537,152 | 2023-10-17T13:32:04.962019 | ChipMOS TECHNOLOGIES INC. researches, develops, manufactures, and sells high-integration and high-precision integrated circuits, and related assembly and testing services in the People's Republic of China, Japan, Singapore, and internationally. It operates through Testing; Assembly; Testing and Assembly for LCD, OLED a... | null | 3,370 |
US | IMPL | NGM | EQUITY | USD | Impel Pharmaceuticals Inc. | Healthcare | Biotechnology | 0.3501 | 4,200 | 8,312,150 | 2023-10-17T13:32:11.383673 | Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute t... | null | 3,371 |
US | IMPP | NCM | EQUITY | USD | Imperial Petroleum Inc. | Energy | Oil & Gas Midstream | 1.92 | 34,046 | 49,621,448 | 2023-10-17T13:32:19.488663 | Imperial Petroleum Inc. provides international seaborne transportation services to oil producers, refineries, and commodities traders. It carries refined petroleum products, such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals, crude oils, iron ore, coal and grains, and minor bulks, su... | null | 3,372 |
US | IMRN | NCM | EQUITY | USD | Immuron Limited | Healthcare | Biotechnology | 1.72 | 467 | 10,849,230 | 2023-10-17T13:32:27.202487 | Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an o... | null | 3,373 |
US | IMRX | NGM | EQUITY | USD | Immuneering Corporation | Healthcare | Biotechnology | 6 | 38 | 176,169,280 | 2023-10-17T13:32:34.144875 | Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, color... | null | 3,374 |
US | IMTB | PCX | ETF | USD | iShares Core 5-10 Year USD Bond ETF | null | null | 40.8122 | 2,445 | 185,002,160 | 2023-10-17T13:32:42.170613 | The fund will invest at least 80% of its assets in the component securities of the index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index. The index measures the performance of U.S. dollar-denominated taxable bonds that... | null | 3,375 |
US | IMTE | NCM | EQUITY | USD | Integrated Media Technology Limited | Technology | Electronic Components | 1.88 | 6,177 | 37,309,124 | 2023-10-17T13:32:47.871758 | Integrated Media Technology Limited engages in the manufacture and sale of laminated switchable glass, nano-coated plate for filters, air purifiers, and Internet of Things (IoT) products. It also engages in the sale of electronic glass; operation of Ouction, a non-fungible token trading marketplace; and provision of ha... | null | 3,376 |
US | IMTM | PCX | ETF | USD | iShares MSCI Intl Momentum Factor ETF | null | null | 31.43 | 182,616 | 1,456,494,080 | 2023-10-17T13:32:54.170570 | The fund will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index. The index consists of stocks exhibiting relatively higher momentum characteristics than the traditiona... | null | 3,377 |
US | IMTX | NCM | EQUITY | USD | Immatics N.V. | Healthcare | Biotechnology | 9.87 | 1,506 | 791,114,368 | 2023-10-17T13:33:01.284991 | Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment mo... | null | 3,378 |
US | IMUX | NMS | EQUITY | USD | Immunic, Inc. | Healthcare | Biotechnology | 1.23 | 48,405 | 55,298,296 | 2023-10-17T13:33:08.336164 | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple... | null | 3,379 |
US | IMVT | NMS | EQUITY | USD | Immunovant, Inc. | Healthcare | Biotechnology | 37.75 | 54,964 | 5,624,198,144 | 2023-10-17T13:33:15.822472 | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical tria... | null | 3,380 |
US | IMXI | NCM | EQUITY | USD | International Money Express, Inc. | Technology | Software - Infrastructure | 16.6 | 2,255 | 587,235,392 | 2023-10-17T13:33:21.773333 | International Money Express, Inc., through its subsidiary, operates as a money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia. The company offers remittance services, which include a suite of ancillary financial processing solutions an... | null | 3,381 |
US | INAB | NGM | EQUITY | USD | IN8bio, Inc. | Healthcare | Biotechnology | 0.9348 | 1,729 | 28,393,590 | 2023-10-17T13:33:29.863197 | IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clin... | null | 3,382 |
US | INBK | NMS | EQUITY | USD | First Internet Bancorp | Financial Services | Banks - Regional | 16.98 | 149 | 146,975,536 | 2023-10-17T13:33:36.126248 | First Internet Bancorp operates as the bank holding company for First Internet Bank of Indiana that provides commercial, small business, consumer, and municipal products and services to individuals and commercial customers in the United States. The company accepts non-interest bearing and interest-bearing demand deposi... | null | 3,383 |
US | INBS | NCM | EQUITY | USD | Intelligent Bio Solutions Inc. | Healthcare | Medical Devices | 0.3 | 46,384 | 1,413,981 | 2023-10-17T13:33:41.906652 | Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerp... | null | 3,384 |
US | INBX | NGM | EQUITY | USD | Inhibrx, Inc. | Healthcare | Biotechnology | 18.2 | 1,634 | 808,298,368 | 2023-10-17T13:33:47.908382 | Inhibrx, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesotheli... | null | 3,385 |
US | INCO | PCX | ETF | USD | Columbia India Consumer ETF | null | null | 54.08 | 1,088 | 119,757,824 | 2023-10-17T13:33:55.924467 | The fund will invest at least 80% of its net assets in Indian consumer companies included in the index and the advisor generally expects to be substantially invested at such times, with at least 95% of its net assets invested in these securities. The index is a maximum 30-stock free-float adjusted market capitalization... | null | 3,386 |
US | INCR | NGM | EQUITY | USD | InterCure Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 1.3 | 590 | 58,333,056 | 2023-10-17T13:34:01.295114 | InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also inv... | null | 3,387 |
US | INCY | NMS | EQUITY | USD | Incyte Corporation | Healthcare | Biotechnology | 57.63 | 10,900 | 12,959,009,792 | 2023-10-17T13:34:09.335262 | Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults wi... | null | 3,388 |
US | INDA | BTS | ETF | USD | iShares MSCI India ETF | null | null | 44.76 | 54,242 | 6,041,856,512 | 2023-10-17T13:34:16.088146 | The fund generally will collectively invest at least 80% of the fund's assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index measures the performance of equity secur... | null | 3,389 |
US | INDB | NMS | EQUITY | USD | Independent Bank Corp. | Financial Services | Banks - Regional | 48.38 | 2,391 | 2,144,539,136 | 2023-10-17T13:34:24.167161 | Independent Bank Corp. operates as the bank holding company for Rockland Trust Company that provides commercial banking products and services to individuals and small-to-medium sized businesses primarily in Massachusetts. It accepts interest checking, money market, and savings accounts, as well as demand deposits and t... | null | 3,390 |
US | INDI | NCM | EQUITY | USD | indie Semiconductor, Inc. | Technology | Semiconductor Equipment & Materials | 5.77 | 106,274 | 891,172,672 | 2023-10-17T13:34:31.762865 | indie Semiconductor, Inc. provides automotive semiconductors and software solutions for advanced driver assistance systems, autonomous vehicle, in-cabin, connected car, and electrification applications in the United States, South America, rest of North America, Greater China, rest of Asia Pacific, and Europe. It offers... | null | 3,391 |
US | INDL | PCX | ETF | USD | Direxion Daily MSCI India Bull 2X Shares | null | null | 48.2509 | 384 | 62,236,648 | 2023-10-17T13:34:37.657390 | The index is designed to measure the performance of the large- and mid-capitalization segments of the Indian equity market, covering approximately 85% of the Indian equity universe. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, ETFs that track the index, securities o... | null | 3,392 |
US | INDO | ASE | EQUITY | USD | Indonesia Energy Corporation Limited | Energy | Oil & Gas E&P | 3.85 | 4,329 | 38,963,184 | 2023-10-17T13:34:46.055336 | Indonesia Energy Corporation Limited operates as an oil and gas exploration and production company in Indonesia. The company holds interests in the Kruh Block, a producing block covering an area of 258 square kilometers with net crude oil proved reserves of 2.06 million barrels located to the northwest of Pendopo, Pali... | null | 3,393 |
US | INDP | NCM | EQUITY | USD | Indaptus Therapeutics, Inc. | Healthcare | Biotechnology | 2.45 | 62 | 21,590,698 | 2023-10-17T13:34:52.707438 | Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumor... | null | 3,394 |
US | INDV | NMS | EQUITY | USD | Indivior PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 19.4 | 5,727 | 2,765,372,672 | 2023-10-17T13:34:58.616684 | Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets an... | null | 3,395 |
US | INFA | NYQ | EQUITY | USD | Informatica Inc. | Technology | Software - Infrastructure | 21.24 | 9,629 | 6,059,499,520 | 2023-10-17T13:35:06.018144 | Informatica Inc. develops an artificial intelligence-powered platform that connects, manages, and unifies data across multi-cloud, hybrid systems at enterprise scale in the United States. The company's platform includes a suite of interoperable data management products, including data integration products to ingest, tr... | null | 3,396 |
US | INFI | PNK | EQUITY | USD | Infinity Pharmaceuticals, Inc. | Healthcare | Biotechnology | 0.008 | 2,476,982 | 726,088 | 2023-10-17T13:35:14.216112 | Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-k... | null | 3,397 |
US | INFN | NMS | EQUITY | USD | Infinera Corporation | Technology | Communication Equipment | 3.58 | 13,271 | 791,964,736 | 2023-10-17T13:35:22.073640 | Infinera Corporation provides optical transport networking equipment, software, and services worldwide. The company's product portfolio includes Infinera Groove series for modular and sled-based platforms to support a various transport network applications; Infinera 7300 series, an SDN-ready coherent optical transport ... | null | 3,398 |
US | INFU | ASE | EQUITY | USD | InfuSystem Holdings, Inc. | Healthcare | Medical Instruments & Supplies | 9.81 | 21,259 | 206,547,600 | 2023-10-17T13:35:28.076366 | InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps... | null | 3,399 |
US | INFY | NYQ | EQUITY | USD | Infosys Limited | Technology | Information Technology Services | 17.21 | 180,518 | 71,289,208,832 | 2023-10-17T13:35:35.641373 | Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application management and application development services, independent validation solutions, product engineering and man... | null | 3,400 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.